OrganiGram Holdings Inc represents a commitment to excellence, sustainability, and innovation in the cannabis industry. With a focus on producing high-quality, organic cannabis products, OrganiGram prioritizes the well-being of its customers and the environment. The company's corporate philosophy is centered around providing safe and reliable cannabis options, while also valuing social responsibility and community engagement. OrganiGram is dedicated to cultivating relationships with its customers, understanding their needs, and consistently delivering superior products. By upholding these core values, OrganiGram Holdings Inc strives to be a trusted leader in the cannabis market.

OrganiGram Holdings Inc is primarily present in Canada.

OrganiGram Holdings Inc has achieved several significant milestones in its operations. Firstly, the company expanded its production capacity through the completion of Phase 3 expansion in 2019. This expansion enabled OrganiGram to increase its annual cannabis production capacity to 76,000 kilograms. Additionally, OrganiGram has successfully developed innovative cannabis derivative products, such as cannabis-infused chocolates and powdered beverages. Moreover, the company has received various certifications, including organic certification by Pro-Cert, which further demonstrates its commitment to producing high-quality and sustainable cannabis products. By focusing on expansion, innovation, and quality, OrganiGram Holdings Inc has established itself as a leading player in the cannabis industry.

OrganiGram Holdings Inc is a Canadian cannabis company that was founded in 2013. It is a licensed producer of medical marijuana, with cultivation facilities located in Moncton, New Brunswick. The company's mission is to provide high-quality, organically-grown cannabis products to both medical and adult-use recreational consumers. OrganiGram Holdings Inc has a strong focus on innovation and sustainability, employing advanced growing techniques and operating under strict quality control measures. With a diverse product line and a commitment to customer satisfaction, OrganiGram Holdings Inc has established itself as a leading player in the cannabis industry.

The main competitors of OrganiGram Holdings Inc in the market include companies such as Canopy Growth Corporation and Aurora Cannabis Inc.

OrganiGram Holdings Inc is primarily active in the cannabis industry.

The business model of OrganiGram Holdings Inc is focused on the cultivation, production, and distribution of high-quality cannabis products. As a leading Canadian licensed producer, OrganiGram operates state-of-the-art indoor facilities to ensure consistent, premium cannabis cultivation. The company's business model revolves around their commitment to innovation, sustainability, and customer satisfaction. By leveraging advanced growing techniques, strategic partnerships, and a diverse product portfolio, OrganiGram aims to cater to both medical and adult-use recreational cannabis markets. With a customer-centric approach and ongoing research and development, OrganiGram Holdings Inc strives to deliver safe, reliable, and exceptional cannabis experiences while contributing to the overall growth of the industry.

OrganiGram Holdings hissesinin F/K oranı -4,12.

OrganiGram Holdings KUV 1,18 dir.

OrganiGram Holdings için AlleAktien Kalite Skoru 5/10'dur.

beklenen OrganiGram Holdings cirosu 162,28 Milyon. CAD dir.

beklenen OrganiGram Holdings karı -46,52 Milyon. CAD olarak gerçekleşmiştir.

OrganiGram Holdings Inc. is a Canadian company specializing in the production, distribution, and marketing of medical cannabis. The business model of OrganiGram includes a wide range of products that can be used for a variety of medical conditions and symptoms. OrganiGram's main focus is the production of cannabis flowers rich in cannabinoids such as THC and CBD. These flowers are offered in different formats, including dried, pressed buds and cured flowers that can be used in capsules or vaporizers. OrganiGram also offers various strains of cannabis flowers specifically developed for different medical conditions or symptoms. In addition to cannabis flowers, OrganiGram also produces various other cannabis products, such as oils and extracts. These products are made from the flowers of the cannabis plant and provide a convenient way to harness the health benefits of cannabis without actually having to smoke or vaporize it. OrganiGram also offers vaporizable oils specifically developed for medical purposes. Another product segment of OrganiGram includes edible products made from cannabis. These include chocolates, candies, and beverages, all of which contain a controlled amount of cannabinoids and are specially developed for medical purposes. OrganiGram also offers a variety of accessories and other products specifically designed for the use of medical cannabis, including vaporizers, capsules, rolling papers, and other utensils suitable for use with OrganiGram's cannabis products. To produce and distribute these products, OrganiGram has developed a comprehensive cultivation system that ensures the flowers and plants are of the highest quality. The company utilizes state-of-the-art technology and methods to ensure the purity, efficacy, and quality of its products. In addition, OrganiGram operates a wide range of online and retail activities to market and sell its products. The company uses a variety of traditional and digital marketing channels to raise awareness of its brand and promote awareness of the health benefits of medical cannabis. Overall, OrganiGram's business model is very diverse and includes a variety of products and services specifically tailored to the use of medical cannabis. Through its innovative research and development, advanced cultivation system, and comprehensive marketing strategy, OrganiGram is able to serve a growing customer base seeking safe and effective products for symptom relief and disease management.

OrganiGram Holdings, yılda kez dağıtılmak üzere 0 CAD tutarında temettü ödemektedir.

OrganiGram Holdings için şu an için temettü hesaplanamıyor veya şirket temettü dağıtmıyor.

OrganiGram Holdings şirketinin ISIN kodu CA68620P1018’dir.

OrganiGram Holdings için Ticker OGI.TO’dir.

Son 12 ay içerisinde OrganiGram Holdings, tutarında bir temettü ödedi. Bu, yaklaşık olarak oranında bir temettü verimine denk gelmektedir. Gelecek 12 ay için OrganiGram Holdings, tahmini olarak 0 CAD tutarında bir temettü ödemesi yapacak.

OrganiGram Holdings şirketinin mevcut temettü verimi .

OrganiGram Holdings dönemsel olarak temettü ödemesi yapar. Bu ödemeler aylarında gerçekleştirilir.

OrganiGram Holdings, son 0 yıl içerisinde her yıl temettü ödedi.

Önümüzdeki 12 ay için 0 CAD tutarında temettü ödenmesi beklenmektedir. Bu, 0 % oranında bir temettü verimidir.

OrganiGram Holdings, 'Sağlık' sektörüne atanmıştır.

Son OrganiGram Holdings tarihinde 0 CAD tutarındaki en son temettüyü alabilmek için, hisseyi 03.10.2024 tarihindeki Ex-Tag'den önce portföyünde bulundurman gerekiyordu.

Son ödeme tarihi 03.10.2024 olarak gerçekleşti.

2023 yılında OrganiGram Holdings tarafından 0 CAD olarak temettüler dağıtıldı.

OrganiGram Holdings hisselerinin temettüleri CAD olarak dağıtılır.